A Study of Tor Kinase Inhibitor in Advanced Tumors
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety, tolerability and pharmacokinetics of
AZD8055 and determine the maximum tolerated dose to take into phase II trials.